| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 72833* | 2016 |
| Dapagliflozin and cardiovascular outcomes in type 2 diabetes SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ... New England Journal of Medicine 380 (4), 347-357, 2019 | 6581 | 2019 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 5481* | 2005 |
| Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ... Circulation 123 (23), 2736-2747, 2011 | 4594 | 2011 |
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ... New England Journal of Medicine 369 (14), 1317-1326, 2013 | 4349 | 2013 |
| Guidelines for the early management of adults with ischemic stroke HP Adams Jr, G Del Zoppo, MJ Alberts, DL Bhatt, L Brass, A Furlan, ... Stroke, 2007 | 4186 | 2007 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3950 | 2006 |
| Alirocumab and cardiovascular outcomes after acute coronary syndrome GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ... New England Journal of Medicine 379 (22), 2097-2107, 2018 | 3434 | 2018 |
| Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ... New England Journal of Medicine 380 (1), 11-22, 2019 | 3277 | 2019 |
| Bariatric surgery versus intensive medical therapy in obese patients with diabetes PR Schauer, SR Kashyap, K Wolski, SA Brethauer, JP Kirwan, CE Pothier, ... New England Journal of Medicine 366 (17), 1567-1576, 2012 | 2960 | 2012 |
| SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome … TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ... The Lancet 393 (10166), 31-39, 2019 | 2872 | 2019 |
| Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes PR Schauer, DL Bhatt, JP Kirwan, K Wolski, A Aminian, SA Brethauer, ... New England Journal of Medicine 376 (7), 641-651, 2017 | 2804 | 2017 |
| A controlled trial of renal denervation for resistant hypertension DL Bhatt, DE Kandzari, WW O'Neill, R D'Agostino, JM Flack, BT Katzen, ... New England Journal of Medicine 370 (15), 1393-1401, 2014 | 2649 | 2014 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2611 | 2017 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2534 | 2012 |
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology … SD Fihn, JM Gardin, J Abrams, K Berra, JC Blankenship, AP Dallas, ... Journal of the American College of Cardiology 60 (24), e44-e164, 2012 | 2451 | 2012 |
| International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda, JL Mas, S Goto, ... Jama 295 (2), 180-189, 2006 | 2355 | 2006 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2247 | 2015 |
| Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American … JS Skyler, R Bergenstal, RO Bonow, J Buse, P Deedwania, EAM Gale, ... Circulation 119 (2), 351-357, 2009 | 2032 | 2009 |
| One-year cardiovascular event rates in outpatients with atherothrombosis PG Steg, DL Bhatt, PWF Wilson, R D’Agostino, EM Ohman, J Röther, ... Jama 297 (11), 1197-1206, 2007 | 1947 | 2007 |